{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:40:10Z","timestamp":1697056810871},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T00:00:00Z","timestamp":1119312000000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Epoetin treatment of renal anemia has been practiced in Slovenia since 1988. More than 90% of hemodialysis patients and 83% of peritoneal dialysis patients have been treated with epoetin. Epoetin has also been available for patients with renal anemia in the pre\u2010dialysis period and for those with a failing kidney allograft. Although epoetin treatment did not accelerate the worsening of native kidney function or allograft function, intensified antihypertensive treatment was required in kidney graft recipients. In patients on peritoneal dialysis, hypervolemia had a greater effect on hypertension than did epoetin treatment. Epoetin resistance was connected with C\u2010reactive peptide cryptorchidism, intact parathyroid hormone, and treatment with angiotensin\u2010converting enzyme inhibitors. In hemodialysis patients, lower doses of epoetin were required for patients receiving low molecular heparin and those with lower iPTH. Epoetin alpha, epoetin beta and epoetin omega seemed to be effective and safe in the treatment of renal anemia. In the past 2\u2003years, epoetins were administered to\u200a hemodialysis\u200a patients\u200a only\u200a intravenously.\u200a<\/jats:p>","DOI":"10.1111\/j.1774-9987.2005.00253.x","type":"journal-article","created":{"date-parts":[[2005,6,21]],"date-time":"2005-06-21T17:12:47Z","timestamp":1119373967000},"page":"202-204","source":"Crossref","is-referenced-by-count":1,"title":["Our Experience With Epoetins in Treating Renal Anemia"],"prefix":"10.1111","volume":"9","author":[{"given":"Andrej","family":"Bren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aljo\u0161a","family":"Kandus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6,21]]},"reference":[{"key":"e_1_2_3_2_2","unstructured":"Buturovi\u010d\u2010PonikvarJ.Renal Replacement Therapy in Slovenia: Annual Report 2003.3rd Slovenian Congress of Nephrology Final Program Invited lectures and Book of Abstracts Brdo pri Kranju2004;23\u201377."},{"key":"e_1_2_3_3_2","first-page":"163","article-title":"Experiences with clinical testing and usage of recombinant human erythropoietin","volume":"47","author":"Kveder R","year":"1996","journal-title":"Farm Vestn"},{"key":"e_1_2_3_4_2","first-page":"99","volume-title":"Book of Abstracts, 16th Danube Symposium on Nephrology, Bled, Slovenia, 19\u201322 September 2002","author":"Pajek J","year":"2002"},{"key":"e_1_2_3_5_2","first-page":"S278.","volume-title":"Book of Abstracts, 13th European meeting on hypertension, 13\u201317 June 2003, Milan, Italy.","author":"Pajek J"},{"key":"e_1_2_3_6_2","first-page":"94","volume-title":"Book of Abstracts, 3rd Slovenian Congress of Nephrology, 29 September\u22122 October 2004, Brdo pri Kranju, Slovenia.","author":"Pajek J","year":"2004"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2002.06844.x"},{"key":"e_1_2_3_8_2","first-page":"154","volume-title":"Proceedings of the 5th BANTAO Congress, 30 September\u20133 October 2001, Thessaloniki, Greece.","author":"Bren A","year":"2001"},{"key":"e_1_2_3_9_2","first-page":"219","volume-title":"Proceedings of the 2nd Slovenian Congress of Nephrology, 27\u201330 September 2000, Ljubljana, Slovenia","author":"Varl J","year":"2000"},{"key":"e_1_2_3_10_2","first-page":"223","volume-title":"Proceedings of the 2nd Slovenian Congress of Nephrology, 27\u201330 September 2000, Ljubljana, Slovenia","author":"Malovrh M","year":"2000"},{"key":"e_1_2_3_11_2","first-page":"227","volume-title":"Proceedings of the 2nd Slovenian Congress of Nephrology, 27\u201330 September 2000, Ljubljana, Slovenia","author":"Premru V","year":"2000"},{"key":"e_1_2_3_12_2","first-page":"A854","article-title":"The impact of serum ferritin and intradialysis anticoagulation mode on epoetin demand in hemodialysis patients","volume":"14","author":"Pajek J","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_3_13_2","first-page":"369","volume-title":"Cardionephrology. Editoriale Bios","author":"Knap B","year":"2004"},{"key":"e_1_2_3_14_2","first-page":"139","volume-title":"Book of Abstracts, 3rd Slovenian Congress of Nephrology, 29 September\u22122 October 2004, Brdo pri Kranju, Slovenia","author":"Varl J","year":"2004"},{"key":"e_1_2_3_15_2","first-page":"A188","article-title":"Kidney allograft function in patients receiving recombinant human erythropoietin","volume":"13","author":"Pajek J","year":"2002","journal-title":"J Am Soc Nephrol"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1774-9987.2005.00253.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1774-9987.2005.00253.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:11:30Z","timestamp":1697055090000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1774-9987.2005.00253.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1111\/j.1774-9987.2005.00253.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1774-9987.2005.00253.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"value":"1744-9979","type":"print"},{"value":"1744-9987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}